By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Omicia, Inc. 

5801 Christie Avenue
Suite 500
Emeryville  California  94608  U.S.A.
Phone: 510-595-0800 Fax: 510-588-4523




Company News
Omicia, Inc. Implements ACMG Variant Scoring And Classification Guidelines To Drive Clinical NGS Report Consistency And Throughput 3/9/2016 11:02:33 AM
Omicia, Inc. Wins UK's 100,000 Genomes Project As Clinical Interpretation Provider 6/4/2015 11:47:05 AM
Omicia, Inc. Introduces Phevor To Boost Identification Of Disease-Causing Gene Mutations 10/29/2014 12:21:17 PM
Omicia, Inc. Introduces Opal Clinical, Interpretation Software For NGS Diagnostics 10/16/2014 8:13:52 AM
Omicia, Inc. And Laboratory Corporation of America Holdings (LabCorp) (LH) Collaborate To Offer Comprehensive Genomic Analysis Services For Next-Generation Clinical Trials 6/3/2014 9:45:18 AM
Dr. Paul Billings Joins Omicia, Inc. As Chief Medical Officer 5/7/2014 9:26:20 AM
Omicia, Inc. Raises $6.8 Million to Accelerate Whole Genome Interpretation 1/7/2014 7:11:58 AM
Omicia, Inc. And University Of Utah Health Sciences Sign Agreement To Use Opal Platform To Analyze And Interpret Personal Genomes For The Clinic 12/4/2013 10:01:38 AM
Spiral Genetics Closes $3 Million in Funding Led by DFJ and Announces Partnership With Omicia, Inc. 3/12/2013 10:40:55 AM
Omicia, Inc. Appoints Mike Aicher as CEO 1/2/2013 7:06:29 AM